Ageing Population, Dementia, Hearing Loss
By 2030, 1.5 billion people will be aged >50 worldwide. 1 in 3 will suffer age acquired disabling sensorineural hearing loss. Treating hearing loss is the single most impactful factor to reduce the risk of dementia.
Cochlear implants (CIs) are proven to be a safe and effective treatment for disabling hearing loss, yet less than 3% of adults aged >50 have received a cochlear implant.
50+ are Underserved and Most at Risk
Key Factors Limiting Update in 50+
Early & Effective Treatment is Key
For potential cochlear implant recipients in the 50+ segment, treatment is typically delayed by many years, potentially impacting their cognitive health (4).
Treating hearing loss early, before it progresses to a profound level can:
Increase outcome predictability and speech understanding (5)
Reduce anxiety and depression (6)
Improve verbal memory and slow cognitive decline (7)
Improve overall heath and quality of life (6)
Hemideina aims to provide a cochlear implant, tailored to the needs of adults aged 50+ to provide a treatment for their hearing loss without compromise.